市場調查報告書
商品編碼
1576653
筆針市場:類型(標準、安全)、針長、用途(一次性、可重複使用)、應用(胰島素、生長激素、GLP-1)、分銷管道(醫院藥房、零售、線上)、使用環境(家庭醫療)護理、醫院)- 2031 年世界預測Pen Needles Market by Type (Standard, Safety), Needle Length, Usability (Disposable, Reuse), Application (Insulin, Growth Hormone, GLP-1), Distribution Channel (Hospital Pharmacy, Retail, Online), Setting (Home Care, Hospital) - Global Forecast to 2031 |
到 2031 年,筆用針頭市場預計將達到 128.8 億美元,2024 年至 2031 年複合年增長率為 9.9%。
經過廣泛的二次和初步研究以及對市場情景的詳細分析,本報告對關鍵行業推動因素、阻礙因素、課題和機會進行了分析。這種增長是由於糖尿病盛行率上升、自我用藥需求增加、技術進步以及醫療保健成本增加所致。然而,對針刺傷的擔憂限制了該市場的成長。
此外,人們對筆式針頭的偏好超過了小瓶和注射器、新興市場、有利的報銷方案以及筆式註射器中人工智慧的引入,預計將為在該市場運營的公司提供成長機會。然而,筆針的重複使用、新興國家獲得醫療保健的機會有限以及缺乏正確使用筆針的意識是影響市場成長的主要課題。
(註:預定提供上位5公司的SWOT分析)
Pen Needles Market by Type (Standard, Safety), Needle Length, Usability (Disposable, Reuse), Application (Insulin, Growth Hormone, GLP-1), Distribution Channel (Hospital Pharmacy, Retail, Online), Setting (Home Care, Hospital)-Global Forecast to 2031
The pen needles market is projected to reach $12.88 billion by 2031 at a CAGR of 9.9% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to the rising prevalence of diabetes, growing demand for self-administration of drugs, advancements in technology, and rising healthcare expenditure. However, the needlestick injury concerns restrain the growth of this market.
Furthermore, the rising preference for pen needles over vials and syringes, emerging economies, favorable reimbursement scenarios, and implementation of AI in pen injectors are expected to generate growth opportunities for the players operating in this market. However, the reuse of pen needles, limited access to healthcare in developing nations, and lack of awareness about proper pen needle usage are major challenges impacting market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the pen needles market are Becton, Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed AG (Switzerland), Owen Mumford Limited (U.K.), B. Braun Melsungen AG (Germany), Terumo Group (Japan), Allison Medical, Inc. (U.S.), Cardinal Health, Inc. (U.S.), UltiMed, Inc. (U.S.), Hindustan Syringes & Medical Devices Ltd (India), and Nanchang YiLi Medical Instrument Co., LTD (China).
Among all the types studied in this report, in 2024, the safety pen needles segment is expected to account for the largest share of the pen needles market. This segment's large share is driven by the benefits offered by safety pen needles, such as reducing the risk of needlestick injuries. Moreover, companies in the pen needles market are actively enhancing their product portfolios through the introduction of new products and obtaining regulatory approvals.
Among all the needle lengths studied in this report, in 2024, the 4 mm segment is expected to account for the larger share of the pen needles market. 4 mm needles have gained popularity as they reduce discomfort and pain associated with insulin injections. Patients find them less uncomfortable than longer needles, which improves adherence to insulin treatment. Therefore, patients who require regular injections often prefer shorter needles, contributing to the significant market share of this segment.
Among all the usabilities studied in this report, in 2024, the single-use/disposable segment is expected to account for the largest share of the pen needles market. Insulin pen needles are intended for single use only, offering several advantages over traditional syringes. Single-use pen needles provide improved dosing accuracy, ease of use, and reduced pain during injections. Additionally, they help to minimize the risk of infections due to their pre-sterilized nature, eliminating the need for cleaning or sterilization before each use, thereby contributing to the increased adoption of single-use/disposable pen needles.
Among all the applications studied in this report, in 2024, the insulin therapy segment is expected to account for the largest share of the pen needles market. This segment's large market share can be attributed to the rising prevalence of diabetes and the increasing awareness among diabetic patients about self-administration of insulin therapy. Furthermore, recent advancements in insulin therapy, such as ultra-long-acting basal insulin and ultra-rapid-acting insulin therapies, provide greater flexibility in the timing of dosing.
Among all the distribution channels studied in this report, in 2024, the retail pharmacies segment is expected to account for the largest share of the pen needles market. This segment's large market share can be attributed to the increasing consumer demand for pen needles and the opportunity for customers to inspect the product before making a purchase.
Among all the end users studied in this report, in 2024, the home care segment is expected to account for the largest share of the pen needles market. This segment's large market share is driven by several factors, including the growing preference among patients for self-administration of medications, technological advancements in pen needles, and the rising number of diabetes cases worldwide.
An in-depth analysis of the geographical scenario of the pen needles market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the pen needles market. In the region in 2024, the U.S. is expected to account for the largest share of the pen needles market in North America. The large share of this regional market is attributed to the presence of major pen needles companies, such as Becton, Dickinson and Company (U.S.) and Cardinal Health, Inc. (U.S.), the high adoption of pen needles devices in home care, and technological advancements in pen needles in the region.
Pen Needles Market Assessment-by Type
Pen Needles Market Assessment-by Needle Length
Pen Needles Market Assessment-by Usability
Pen Needles Market Assessment-by Application
Note: Other Applications include Osteoporosis, psoriasis, multiple sclerosis, and rheumatoid arthritis.
Pen Needles Market Assessment-by Distribution Channel
Pen Needles Market Assessment-by Healthcare Setting
Note: Other Healthcare Settings include nursing care centers, long-term care settings, and ambulatory care centers.
Pen Needles Market Assessment-by Geography
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)